Denali Therapeutics Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC DNLI

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

4,983,726

Value ($000)

82,281

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	82,281	0.0%	4,983,726	12/31/2025
2025 Q3	11/14/2025	79,352	0.0%	5,465,037	9/30/2025
2025 Q2	8/14/2025	87,609	0.0%	6,262,277	6/30/2025
2025 Q1	5/19/2025	91,996	0.0%	6,766,916	3/31/2025
2024 Q4	2/14/2025	73,019	0.0%	3,582,874	12/31/2024
2024 Q3	11/14/2024	109,223	0.0%	3,749,486	9/30/2024
2024 Q2	8/14/2024	53,353	0.0%	2,297,716	6/30/2024
2024 Q1	5/15/2024	14,102	0.0%	687,239	3/31/2024
2023 Q4	2/14/2024	15,201	0.0%	708,339	12/31/2023
2023 Q3	11/13/2023	13,271	0.0%	643,300	9/30/2023
2023 Q2	8/11/2023	13,067	0.0%	567,141	6/30/2023
2023 Q1	5/15/2023	13,067	0.0%	567,141	3/31/2023
2022 Q4	2/14/2023	15,127	0.0%	543,923	12/31/2022
2022 Q3	11/14/2022	16,272	0.0%	530,204	9/30/2022
2022 Q2	8/12/2022	14,344	0.0%	487,405	6/30/2022
2022 Q1	5/16/2022	13,988	0.0%	434,827	3/31/2022
2021 Q4	2/14/2022	19,626	0.0%	440,036	12/31/2021
2021 Q3	11/15/2021	21,932	0.0%	434,734	9/30/2021
2021 Q2	8/16/2021	33,719	0.0%	429,871	6/30/2021
2021 Q1	5/14/2021	17,032	0.0%	298,284	3/31/2021
2020 Q4	3/1/2021	34,315	0.0%	409,683	12/31/2020
2020 Q3	11/13/2020	17,733	0.0%	494,907	9/30/2020
2020 Q2	8/14/2020	11,913	0.0%	492,669	6/30/2020
2020 Q1	5/15/2020	1,158	0.0%	66,141	3/31/2020
2019 Q4	2/14/2020	1,008	0.0%	57,855	12/31/2019